Invention Grant
- Patent Title: Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
-
Application No.: US17282521Application Date: 2019-10-04
-
Publication No.: US11535618B2Publication Date: 2022-12-27
- Inventor: Alex J. Buckmelter , Justin Andrew Caravella , Hongbin Li , Matthew W. Martin , Steven Mischke , David James Richard , Angela V. West
- Applicant: FORMA Therapeutics, Inc.
- Applicant Address: US MA Watertown
- Assignee: FORMA Therapeutics, Inc.
- Current Assignee: FORMA Therapeutics, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Choate, Hall & Stewart LLP
- Agent John P. Rearick; Erica M. D'Amato
- International Application: PCT/US2019/054803 WO 20191004
- International Announcement: WO2020/072964 WO 20200409
- Main IPC: C07D471/18
- IPC: C07D471/18 ; C07D403/12 ; C07D471/08 ; C07D487/08 ; C07D487/18 ; C07D491/107
Abstract:
The disclosure relates to USP30 Inhibitor Compounds I, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, and medical uses involving same. (I)
Public/Granted literature
- US20210355126A1 FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS Public/Granted day:2021-11-18
Information query
